Malignant Head and Neck Mucosal Neoplasm

Malignant Head and Neck Mucosal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

466 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 163
Recruiting: 80
Ph III recruiting: 9
Growth YoY: +33.3%
Industry share: 7%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (63)

clinicaltrialsPublishedShowing 51–98 of 98 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07497607	Reduced Elective Nodal and CTV Dose for HPV+ Oropharyngeal Squamous Cell Carcinoma(REDUCE-30)	recruiting	Phase 2	31	Sara MedekOTHER	1	May 18, 2026	clinicaltrials
NCT05541016	De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA	recruiting	Phase 2	455	Mayo ClinicOTHER	1	May 12, 2026	clinicaltrials